Artificial Intelligence Measured Tumor Burden and Pre‐Treatment Circulating Tumor DNA in Human Papilloma Virus‐Associated Oropharynx Cancer
Head & Neck · 2025
DOI: 10.1002/hed.28180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Mina Bakhtiar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Radiation Oncology Program, Brigham & Women's Hospital and Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Artificial Intelligence, Tumor Burden, Circulating Tumor DNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NIBIB NIH HHS, AHRQ HHS.
Abstract (Originalsprache)
Background
Artificial intelligence (AI)‐based imaging analysis and circulating tumor‐associated DNA (ctDNA) are both being used diagnostically in HPV‐driven oropharynx squamous cell carcinoma (HPV‐OPSCC). We evaluated associations between AI‐measured tumor burden and ctDNA.
Methods
We analyzed 170 patients treated definitively for HPV‐OPSCC. All had pre‐treatment serum tumor‐tissue modified viral (TTMV) ctDNA levels. An AI algorithm measured tumor and lymph nodes on CT scans. Linear regressions detected associations between ctDNA (fragments/mL) and automated volumes, clinical tumor (T) and nodal (N) stage, and disease factors.
Results
Automated tumor volume (coeff = 39.43, p < 0.001), nodal volume (coeff = 39.54, p < 0.001), T stage (coeff = 1031.09, p = 0.009), and N stage (coeff = 1840, p = 0.018) were associated with ctDNA. On multivariable analysis, tumor (coeff = 34.79, p = 0.001) and nodal volumes (coeff = 24.68, p = 0.022) were associated with ctDNA; T and N stage were not.
Conclusions
Automated volumetrics are independently and more strongly associated with ctDNA, compared with clinical stage. Automated volumetrics provide a practical correlate to ctDNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard Radiation Oncology Program, Brigham & Women's Hospital and Massachusetts General Hospital, Boston, Massachusetts, USA.
- Artificial Intelligence in Medicine (AIM) Program, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Radiation Oncology, Brigham & Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Radiation Oncology, Mayo Clinic Jacksonville, Jacksonville, Florida, USA.
- Division of Neuroradiology, Brigham & Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Head and Neck Surgery, Brigham & Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA.
ORCID-Profile: Mina Bakhtiar
Förderung
- NIDCR NIH HHS
- NIBIB NIH HHS
- AHRQ HHS
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Bakhtiar, M., Ye, Z., Schoenfeld, J. D., Mohammadi, H., Guenette, J. P., Rettig, E. M., Hanna, G. J., & Kann, B. H. (2025). Artificial Intelligence Measured Tumor Burden and Pre‐Treatment Circulating Tumor DNA in Human Papilloma Virus‐Associated Oropharynx Cancer. Head & Neck. https://doi.org/10.1002/hed.28180
Vancouver
Bakhtiar M, Ye Z, Schoenfeld JD, Mohammadi H, Guenette JP, Rettig EM, et al. Artificial Intelligence Measured Tumor Burden and Pre‐Treatment Circulating Tumor DNA in Human Papilloma Virus‐Associated Oropharynx Cancer. Head & Neck. 2025. doi:10.1002/hed.28180
BibTeX
@article{Bakhtiar2025,
author = {Bakhtiar, Mina and Ye, Zezhong and Schoenfeld, Jonathan D and Mohammadi, Homan and Guenette, Jeffrey P and Rettig, Eleni M and Hanna, Glenn J and Kann, Benjamin H},
title = {Artificial Intelligence Measured Tumor Burden and Pre‐Treatment Circulating Tumor DNA in Human Papilloma Virus‐Associated Oropharynx Cancer},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28180}
}
EUVIMED